Results 151 to 160 of about 9,725,589 (384)

Digital Behavioral Therapy Improves Outcome in Patients With Axial Spondyloarthritis and Persistent Pain: A Randomized Controlled Trial

open access: yesArthritis Care &Research, EarlyView.
Objective Axial spondyloarthritis (axSpA) is often associated with persistent pain despite effective anti‐inflammatory treatment. Digital health applications (DHAs) provide innovative approaches to address multidimensional aspects of persistent pain through psychological and behavioral strategies. The aim of this study was to assess the impact of a DHA
David Kiefer   +7 more
wiley   +1 more source

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis

open access: yesJournal of Translational Medicine
Background Sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B) is emerging as a potential biomarker and therapeutic target in myalgic encephalomyelitis (ME), a complex multisystem disorder characterized by immune dysfunction, metabolic disturbances ...
Bita Rostami-Afshari   +12 more
doaj   +1 more source

The primary role of radiological imaging in the diagnosis of rare musculoskeletal diseases. Emphasis on ultrasound

open access: yesJournal of Ultrasonography, 2019
Objective: In July 2017 a multidisciplinary clinical Center specialized in rare diseases was activated. A rare disease can involve the musculoskeletal system. A multimodality musculoskeletal imaging approach allows for a rapid diagnosis.
Federica Rossi   +6 more
doaj   +1 more source

Decreasing Medical Complications for Total Knee Arthroplasty: Effect of Critical Pathways on Outcomes [PDF]

open access: yes, 2010
BACKGROUND: Studies on critical pathway use have demonstrated decreased length of stay and cost without compromise in quality of care. However, pathway effectiveness is difficult to determine given methodological flaws, such as small or single center ...
Fossel, Anne H.   +5 more
core   +3 more sources

Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1)

open access: bronze, 2021
Marco Garrido‐Cumbrera   +5 more
openalex   +2 more sources

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Biphasic control of the B cell transcriptome by mTORC1 and GSK3

open access: yesCell Reports
Summary: A central question in immune regulation is how cells coordinate transcriptional responses to environmental cues. It remains unclear whether transcriptional regulation is controlled by isolated mechanism or integrated regulatory programs.
Jens Kalchschmidt   +10 more
doaj   +1 more source

Process and Analysis of Kidney Infiltrates by Flow Cytometry from Murine Lupus Nephritis

open access: yesBio-Protocol, 2012
Methods for the isolation and characterization of mononuclear phagocytes from the kidneys of mice with SLE are essential to understand the patho-physiology of the disease. Activation of these cells is associated with the onset of clinical disease in mice
Ramalingam Bethunaickan, Anne Davidson
doaj   +1 more source

Guidelines for the management of the foot health problems associated with rheumatoid arthritis [PDF]

open access: yes, 2011
Background. Rheumatoid arthritis (RA) as a chronic systemic disease, commonly affects the feet, impacting negatively on patients' quality of life. Specialist podiatrists have a prime role to play in the assessment and management of foot and ankle ...
Bowen, C   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy